Nursing significance
Maternal hypertension poses a high risk of morbidity and mortality for women as well as newborn babies. Careful measurement of key indicators of maternal hypertension by nurses helps to alleviate the drastic outcomes the disease may result in.
Early prevention tools such as blood pressure self-monitoring in pregnancy and the adoption of a new blood pressure cut-off for the hypertensive disorders can significantly reduce the morbidity and mortality rates (Sisti & Williams, 2019). The application of these tools in nursing practice will lead to significant reduction of risks for pregnant women.
The onset of maternal hypertension is characterized by the change in markers such as placental growth factor, plasma protein, and mean arterial blood pressure that nurses are trained to measure and record. The drastic change in the results analysis may point to nurses the beginning of material hypertension.
Position on the issue
Nurses should adopt new cut-off standards and advise self-monitoring to pregnant women to reduce the risks of material hypertension onset. Moreover, markers should be carefully measured to offset the possibility of the decease development.
Nurses’ impact on maternal hypertension
Nurses improve the maternal hypertension outcomes by adhering to new standards of disease recognition and adopting preventive measures necessary to offset the start of the decease (Hinton et al., 2017).
Nurses assess the risks of maternal hypertension development by measuring health indicators that allow to judge the progress of the disease (Mayrink et al., 2020).
Nurses see to it that the smallest changes in the women’s state are not ignored and properly reported, thus, enhance the number of positive outcomes for women with maternal hypertension.
References
Hinton, L., Tucker, K. L., Greenfield, S. M., Hodgkinson, J. A., Mackillop, L., McCourt, C., & McManus, R. J. (2017). Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women’s experiences of self-monitoring. BMC pregnancy and childbirth, 17(1), 1-9.
Mayrink, J., Leite, D. F. B., Costa, M. L., & Cecatti, J. G. (2020). Metabolomics for prediction of hypertension in pregnancy: A systematic review and meta-analysis protocol. BMJ open, 10(12), e040652.
Sisti, G., & Williams, B. (2019). Body of evidence in favor of adopting 130/80 mm Hg as new blood pressure cut-off for all the hypertensive disorders of pregnancy. Medicina, 55(10), 703.